Results 231 to 240 of about 1,438,452 (291)

The role of chronic heart failure in the onset of fibrillation atria

CONFERENCE MATERIALS, 2019
openaire   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen   +27 more
wiley   +1 more source

The 3D printed cardiac model: a potential tool in transcatheter complex atrial septal defect closure-a case report study. [PDF]

Eur Heart J Case Rep
Nieuwendijk JD, Geerlings A, Baan J, Bouma BJ, Grundeken MJ.   +4 more
europepmc   +1 more source

Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi, Alvin Chandra, Ambarish Pandey, Marco Metra   +3 more
wiley   +1 more source

Transmural heterogeneity in 3D fibrosis distribution is associated with endo-epicardial electrical dyssynchrony in persistent atrial fibrillation. [PDF]

J Physiol
Ali SY, Mohsen Y, Sabareesan S, Loeffler S, Yamamoto C, Prakosa A, Kholmovski EG, Spragg D, Calkins H, Sakata K, Trayanova N.   +10 more
europepmc   +1 more source

Sodium Channel Isoform Diversity Underlies Chamber-Specific Cardiac Excitability. [PDF]

Circ Res
Clark CJ, Anderson CE, Dou A, Dierdorff JM, Galpin JD, Gissot L, Thompson SG, Choi H, Yoon JY, Infield DT, McLendon JM, Hoeger JM, Rabab'h O, Bronk P, Leeds K, Kutschke WJ, Paradee WJ, Boudreau RL, Choi BR, London B, Ahern CA.   +20 more
europepmc   +1 more source

Heme oxygenase/carbon monoxide system and cardiac conduction system. [PDF]

Med Gas Res
Mahan VL.
europepmc   +1 more source

Ischemic Stroke, Major Bleeding and Death Following Oral Anticoagulation for Atrial Fibrillation Among Elderly Long-term Care Residents With Chronic Kidney Disease. [PDF]

Kidney Med
Harel Z, Kang Y, Stirling K, Ray JG, Win SL.   +4 more
europepmc   +1 more source

Selective loss of Cx40 and conduction abnormalities underlie enhanced atrial fibrillation susceptibility in a HFpEF model in male mice. [PDF]

Physiol Rep
Kawajiri K, Iwamiya S, Yaga L, Yamazoe M, Ihara K, Soejima Y, Sasano T.   +6 more
europepmc   +1 more source